NCT06442189

Brief Summary

The aim was to evaluate the effects of the application of a Mediterranean diet on the reproductive and metabolic parameters in the 3rd month in patients with a body mass index of 25 and more who were followed up in our clinic due to a PCOS diagnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 4, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

September 20, 2024

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 7, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2024

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

17 days

First QC Date

May 18, 2024

Last Update Submit

November 16, 2024

Conditions

Keywords

polycystic ovary syndromeMediterranean dietobesity

Outcome Measures

Primary Outcomes (4)

  • the effect of applying a Mediterranean diet on Homa-IR in PCOS

    Homeostasis model assessment (HoMA)-IR

    3 months

  • PREDIMED in PCOS

    PREDIMED questionnaire

    3 months

  • the effect of applying a Mediterranean diet on glucose in PCOS

    Fasting plasma glucose

    3 months

  • the effect of applying a Mediterranean diet on HbA1c in PCOS

    HbA1c values

    3 months

Study Arms (1)

3. month

Once the baseline values have been determined at the first visit, all tests are repeated after the diet has been followed for 3 months.

Dietary Supplement: Mediterranean Diet

Interventions

Mediterranean DietDIETARY_SUPPLEMENT

The aim was to evaluate the effects of the application of a Mediterranean diet on the reproductive and metabolic parameters in the 3rd month of patients with a body mass index of 25 and more who were treated in our clinic due to a diagnosis of PCOS.

Also known as: Baseline, 3. Month
3. month

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

People receiving care at the PCOS Clinic of Etlik Zübeyde Hanım Gynecology Training and Research Hospital who have a body mass index of 25 or more and follow a Mediterranean diet will be included in the study group. 98 subjects who agreed to participate in the study and accepted the informed consent verbally and in writing will be included in the study. The study was designed to be prospective. Data will be collected after 0 and 3 months.

You may qualify if:

  • At the age of 18-40 years,
  • No underlying metabolic disease (type 2 diabetes, hypertension, diagnosed anemia),
  • With a body mass index of 25 and above,
  • Female patients attending the PCOS clinic and under the care of our hospital's dietitian will be enrolled in the study.

You may not qualify if:

  • Age \< 18 and \> 40 years;
  • Menopause, pregnancy or breastfeeding in the last 6 months;
  • Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary etiologies, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction and adrenal disorders),
  • Pre-existing systemic or psychiatric disease
  • Use of drugs that affect carbohydrate or lipid metabolism (oral contraceptive pills, metformin, anti-epileptics, antipsychotics, statins and fish oil);
  • Certain eating regimens or hypocaloric diet in the last three months; supplementing with antioxidants, vitamins or minerals;
  • Non-steroidal anti-inflammatory drugs, diuretics, etc. use of medications that may affect fluid balance
  • Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of interference with device activity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Etlik Zübeyde Hanım

Ankara, 06000, Turkey (Türkiye)

Location

Related Publications (2)

  • Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999 Jan;84(1):165-9. doi: 10.1210/jcem.84.1.5393.

  • Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, Pugliese G, Colao A, Savastano S. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019 Sep 23;11(10):2278. doi: 10.3390/nu11102278.

MeSH Terms

Conditions

Polycystic Ovary SyndromeFeeding BehaviorObesity

Interventions

Diet, MediterraneanBaseLine dental cement

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesBehavior, AnimalBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Mujde Can Ibanoglu

    Ankara Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof

Study Record Dates

First Submitted

May 18, 2024

First Posted

June 4, 2024

Study Start

September 20, 2024

Primary Completion

October 7, 2024

Study Completion

November 11, 2024

Last Updated

November 19, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations